Dihydronicotinamide riboside, CAS [[19132-12-8]]

Produktübersicht

• Artikelname: Dihydronicotinamide riboside, CAS [[19132-12-8]]
• Artikelnummer: MCE-HY-W614507
• Hersteller Artikelnummer: HY-W614507
• Alternativnummer: MCE-HY-W614507-100MG,MCE-HY-W614507-5MG,MCE-HY-W614507-25MG,MCE-HY-W614507-10MG,MCE-HY-W614507-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Dihydronicotinamide riboside is a potent NAD+ concentration enhancer. Dihydronicotinamide riboside modulates targets BAX, PUMA, NQO2, and IkappaB kinase. Dihydronicotinamide riboside mediates apoptosis, induces pro-oxidant activity, mitochondrial dysfunction, metabolic dysregulation, redox modulation, and pro-inflammatory M1 phenotype induction. Dihydronicotinamide riboside increases intracellular and mitochondrial NAD+ levels, maintains cell survival against NAD+-depleting genotoxins. Dihydronicotinamide riboside can be used for the research of hepatocellular carcinoma[1][2][3].

Produkteigenschaften

• Molekulargewicht: 256.26
• Reinheit: 98
• CAS Nummer: [19132-12-8]
• Formel: C11H16N2O5
• Target-Kategorie: Apoptosis,Bcl-2 Family,NADPH Oxidase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound